furthermore if OSX is a 60 million market cap with 3 million in cash as a biotech which is trialing in Singapore on a biotech with a small target market and NYR is a 16 million market cap with 10 million in cash in the same position in the life cycle of a biotech company which the target market is 50 billion dollar market with stroke and traumatic brain injury yeh it’s severely undervalued and give me that easy accumulation
Always about fundamentals doesn’t matter about the day traders it matters about what’s already proven and the news flow hitting short term further developing this multi billion dollar drug
NYR Price at posting:
9.4¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)